CytoDyn Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | $42.2M | $-94.4M | $4.2M |
| FY2023 | $45.7M | $-109.5M | $2.5M |
| FY2024 | $45.0M | $-116.8M | $3.1M |
| FY2025 | $45.4M | $-96.0M | $11.9M |
| FY2026 | $38.3M | $-109.7M | $11.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | $42.2M | $-94.4M | $4.2M |
| FY2023 | $45.7M | $-109.5M | $2.5M |
| FY2024 | $45.0M | $-116.8M | $3.1M |
| FY2025 | $45.4M | $-96.0M | $11.9M |
| FY2026 | $38.3M | $-109.7M | $11.9M |